Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure.
Cataliotti A, Schirger JA, Martin FL, Chen HH, McKie PM, Boerrigter G, Costello-Boerrigter LC, Harty G, Heublein DM, Sandberg SM, James KD, Miller MA, Malkar NB, Polowy K, Burnett JC Jr.
Cataliotti A, et al. Among authors: chen hh.
Circulation. 2005 Aug 9;112(6):836-40. doi: 10.1161/CIRCULATIONAHA.105.538520. Epub 2005 Aug 1.
Circulation. 2005.
PMID: 16061734
Clinical Trial.